Effect of nicotinamide riboside on skeletal muscle and metabolic health: a randomized, placebo-controlled trial
Dollerup OL, Christensen B, Svart M
Published in American Journal of Clinical Nutrition
Key Findings
Twelve weeks of an NAD+ precursor did not improve insulin sensitivity, mitochondrial function or body composition in obese men.
Conclusions
Well-designed null result for NAD+ boosting.
Limitations
Male-only, obese cohort.
Supplements Studied
An NAD+ precursor did not improve insulin sensitivity, mitochondrial function or body composition over 12 weeks.
Twelve weeks of an NAD+ precursor did not improve insulin sensitivity, mitochondrial function or body composition in obese men.
Outcomes Measured
Mitochondrial function and metabolic health were unchanged after 12 weeks of NAD+ precursor supplementation.
Twelve weeks of an NAD+ precursor did not improve insulin sensitivity, mitochondrial function or body composition in obese men.
Twelve weeks of an NAD+ precursor did not improve insulin sensitivity, mitochondrial function or body composition in obese men.
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.